Macrophages are often called the immune system's garbage collectors. They patrol the body and swallow up dead, dying, and damaged cells — a process called efferocytosis — then tidy up the scene to keep tissues calm. Neutrophils, by contrast, are first responders: they rush to infection and injury, do their job, and then become senescent (worn out) within hours.

A team at Stanford Medicine, led by researcher Kenneth Andreasson, set out to understand what happens when this handoff breaks down as we grow older. In aging mice and human tissue samples, they found that tissue-resident macrophages — the stationary collectors living in each organ — steadily lose their ability to clear senescent neutrophils. The result is a backlog of dying cells, which seep out inflammatory signals and damage surrounding tissue.

The researchers identified the specific molecular switch behind the failure: a receptor called EP2, activated by a hormone-like molecule known as prostaglandin E2. When EP2 signaling runs too high in aging macrophages, clearance stalls. When the team gently reduced that signaling in old mice, the macrophages resumed their cleanup, and the animals showed signs of improved tissue health — including more youthful mitochondria and less chronic inflammation — across multiple organs.

Why does this matter? Because chronic, low-grade inflammation — often called "inflammaging" — is a common thread in most age-related diseases, from heart disease to cognitive decline. The study reframes a big part of aging not as simple wear and tear, but as a breakdown in a routine maintenance job that the immune system performs every single day.

Knowledge takeaway: Aging partly results from a failure of macrophages to clear senescent neutrophils, driven by overactive EP2/prostaglandin E2 signaling. Restoring this cleanup in mice reduced inflammation and improved tissue health — suggesting a new, immune-focused target for therapies aimed at the root of age-related decline.